Mpox, AIDS and COVID-19 show the challenges of targeting public health messaging to specific groups without causing stigma

Prejudice and stigma can discourage the communities most affected by infectious diseases from seeking care. Inclusive public health messaging can prevent misinformation and guide the most vulnerable.

Ken Ho, Assistant Professor of Infectious Diseases, University of Pittsburgh Health Sciences • conversation
Dec. 14, 2022 • ~9 min

Gonorrhea became more drug resistant while attention was on COVID-19 – a molecular biologist explains the sexually transmitted superbug

The US currently has only one antibiotic available to treat gonorrhea – and it’s becoming less effective.

Kenneth Keiler, Professor of Biochemistry and Molecular Biology, Penn State • conversation
Oct. 5, 2022 • ~8 min

Manuscripts and art support archaeological evidence that syphilis was in Europe long before explorers could have brought it home from the Americas

The idea that Europeans brought new diseases to the Americas and returned home with others has been widely accepted. But evidence is mounting that for syphilis this scenario is wrong.

Marylynn Salmon, Research Associate in History, Smith College • conversation
July 13, 2022 • ~10 min

Why COVID-19 must be included in safer sex messaging on college campuses

Schools have not adequately educated students about the increased risks of virus transmission when it comes to being sexually intimate.

Michele R. Cooley-Strickland, Project Scientist and Clinical Psychologist, Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine • conversation
Dec. 2, 2021 • ~9 min

Contact tracing's long, turbulent history holds lessons for COVID-19

Trust in the confidentiality of contact tracing broke down during the AIDS epidemic. Today, it's faltering again.

Ronald Bayer, Professor Sociomedical Sciences, Columbia University • conversation
July 16, 2020 • ~10 min

/

1